ZUNVEYL Delayed release tablet Ref.[116136] Active ingredients: Galantamine

Source: FDA, National Drug Code (US)  Revision Year: 2025 

Product description

ZUNVEYL (benzgalantamine) is a prodrug of galantamine, an acetylcholinesterase inhibitor . Benzgalantamine gluconate is known chemically as (4aS,6R,8aS)-4a,5,9,10,11,12-hexahydro-3-methoxy-11-methyl-6H-benzofuro[3a,3,2-ef][2]benzazepin-6-benzoate gluconate salt. It has an empirical formula of C30H37NO11 and has a molecular weight of 587.61 (gluconate salt) and 391.46 (benzgalantamine). Benzgalantamine gluconate is a white to pale yellow powder and is soluble in water. Benzgalantamine has a pH of 5 to 6 and dissociation constant (pKa) of 7.0. It is slightly soluble in methanol and practically insoluble in acetone, acetonitrile and hexane. The structural formula for benzgalantamine gluconate is:

ZUNVEYL contains 5 mg, 10 mg, 15 mg benzgalantamine equivalent to 7.49 mg, 14.98 mg, and 22.47 mg benzgalantamine gluconate, respectively. ZUNVEYL delayed-release tablets are for oral use. Inactive ingredients include calcium silicate, colloidal silicon dioxide, hypromellose, magnesium stearate, mannitol, methacrylic acid, poloxamer 407, polyethylene glycol/macrogol, sodium bicarbonate, sodium lauryl sulfate, sodium stearyl fumarate, talc, and titanium dioxide. The 10 mg tablet also contains Carmine, FD&C Blue #2/Indigo Carmine Aluminum Lake, and FD&C Red #40/Allura Red AC Aluminum Lake. The 15 mg tablet also contains FD&C Blue #2/Indigo Carmine Aluminum Lake, FD&C Red #40/Allura Red AC Aluminum Lake, and FD&C Yellow #6/Sunset Yellow FCF Aluminum Lake.

Dosage Forms and Strengths

ZUNVEYL delayed-release tablets are enteric coated and available in the following strengths of benzgalantamine:

  • 5 mg white, round, and convex, debossed with "B05" in grey
  • 10 mg purple, round, and convex, debossed with "B10" in grey
  • 15 mg grey, round, and convex, debossed with "B15" in dark grey
How Supplied

ZUNVEYL delayed-release tablets are enteric coated and supplied in child-resistant packages as follows:

  • 5 mg white tablet debossed with "B05" in grey – bottles of 60 (NDC 84054-005-60)
  • 10 mg purple tablet debossed with "B10" in grey – bottles of 60 (NDC 84054-010-60)
  • 15 mg grey tablet debossed with "B15" in dark grey – bottles of 60 (NDC 84054-015-60)

ZUNVEYL delayed-release tablets are manufactured for: Alpha Cognition, Inc., 1452 Hughes Rd, Suite 200, Grapevine, TX 76051

Drugs

Drug Countries
ZUNVEYL United States

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.